brain-computer interface AI News & Updates
Science Corp. Advances Biohybrid Brain-Computer Interface Toward First Human Trials
Science Corporation, founded by former Neuralink president Max Hodak, is preparing to conduct first US human trials of a biohybrid brain-computer interface that combines lab-grown neurons with electronics. The company has recruited Yale neurosurgeon Dr. Murat Günel to lead trials of an advanced sensor that will rest on the brain's surface, with initial tests planned for patients already requiring brain surgery. Unlike conventional electrode-based BCIs, this approach aims to create biological integration between electronics and the brain to treat neurological conditions and potentially enable human enhancement.
Skynet Chance (+0.04%): The development of biohybrid interfaces that integrate lab-grown neurons with electronics represents a novel pathway for brain-computer integration with potentially more durable and sophisticated control mechanisms. While currently focused on medical applications, the explicit goal of human enhancement and adding new senses introduces alignment challenges around augmented cognitive capabilities.
Skynet Date (+0 days): This represents an alternative technological pathway to brain-computer interfaces that may take longer to mature than conventional electrode approaches, slightly delaying potential risks. However, if successful, biological integration could ultimately enable more powerful human-AI coupling than current methods.
AGI Progress (+0.03%): Biohybrid brain-computer interfaces could enable more sophisticated bidirectional communication between biological and artificial intelligence systems, representing progress toward tighter integration of human cognition with AI. The biological approach may overcome limitations of electrode-based systems and enable more complex neural interfacing crucial for AGI-human collaboration.
AGI Date (+0 days): The $1.5 billion valuation and $230 million funding, combined with concrete plans for human trials by 2027, accelerates development of advanced brain-computer interfaces. This technology could speed pathways to AGI by enabling direct neural interfaces for AI systems to interact with human intelligence and learn from biological neural processing.
OpenAI Leads $250M Investment in Sam Altman's Brain-Computer Interface Startup Merge Labs
OpenAI has invested in CEO Sam Altman's brain-computer interface startup Merge Labs, leading its $250 million seed round at an $850 million valuation. The company aims to develop non-invasive neural interfaces using molecules and ultrasound to connect humans with AI, competing with Elon Musk's Neuralink. The investment raises concerns about circular dealing, as Merge Labs could function as a "remote control" for OpenAI's software, potentially driving users to OpenAI while increasing the value of Altman's personal holdings.
Skynet Chance (+0.06%): Direct integration of human brains with AI systems creates new pathways for loss of human agency and potential manipulation of neural activity by AI systems. The goal of "merging" humans with superintelligent AI to survive it paradoxically increases dependency and control risks.
Skynet Date (-1 days): The substantial $250M investment and OpenAI's direct involvement accelerates the timeline for human-AI integration, which Altman explicitly frames as necessary for humanity's survival against superintelligent AI. This suggests expectations of advanced AI capabilities arriving sooner than previously anticipated.
AGI Progress (+0.04%): Brain-computer interfaces represent a significant expansion of AI capabilities by providing direct neural data and control mechanisms, potentially accelerating feedback loops between human intelligence and AI systems. OpenAI's commitment to developing AI operating systems that interpret neural signals indicates progress toward more general intelligence applications.
AGI Date (-1 days): The major investment and OpenAI's plans to integrate scientific foundation models with neural interface technology accelerates multiple AGI-relevant research streams simultaneously. The timeline acceleration is evidenced by Altman's 2017 prediction of a merge between 2025-2075, with active development now underway in 2026.
OpenAI CEO Sam Altman Discusses GPT-5 Reception and Company's Expansion Beyond AI Models
OpenAI CEO Sam Altman hosted tech reporters for dinner following GPT-5's launch, which performed on par with competitors rather than exceeding expectations like GPT-4 did. Altman outlined OpenAI's broader ambitions beyond AI models, including plans for consumer apps, an AI browser to compete with Chrome, social media applications, and investments in brain-computer interfaces through Merge Labs.
Skynet Chance (+0.04%): OpenAI's expansion into browsers, social media, and brain-computer interfaces increases AI integration across multiple critical platforms, potentially creating more avenues for AI systems to influence human behavior and decision-making. The diversification beyond pure AI models into infrastructure and consumer applications could increase systemic dependencies on AI.
Skynet Date (-1 days): OpenAI's aggressive expansion into multiple sectors and infrastructure (browsers, social media, BCI) accelerates AI integration into critical systems, though the relatively modest performance gains of GPT-5 suggest some deceleration in core capability advancement. The net effect slightly accelerates timeline through broader deployment.
AGI Progress (-0.01%): GPT-5's performance being merely on par with competitors rather than a significant leap suggests slower progress in core AI capabilities compared to the transformative jump from GPT-3 to GPT-4. This represents a plateauing in the most advanced model development.
AGI Date (+0 days): The disappointing GPT-5 performance relative to expectations suggests potential slowdown in the rapid capability scaling that characterized earlier GPT iterations. However, OpenAI's diversification strategy may indicate they're focusing resources on deployment rather than pure capability advancement, which could delay AGI timeline.
Sam Altman Co-Founding Brain-Computer Interface Startup to Challenge Neuralink
Sam Altman is reportedly co-founding Merge Labs, a brain-computer interface startup valued at $850 million, with potential funding from OpenAI's ventures team. The company will compete directly with Elon Musk's Neuralink in developing technology that allows humans to control devices with their thoughts. This move represents Altman's entry into the "merge" between human intelligence and artificial systems, continuing his vision of human-AI integration first outlined in 2017.
Skynet Chance (+0.04%): Brain-computer interfaces create new potential attack vectors for AI systems to directly interface with human cognition, potentially enabling unprecedented forms of AI influence or control over human decision-making. However, the technology is still early-stage and primarily focused on assistive applications.
Skynet Date (-1 days): The development accelerates human-AI integration research and creates competitive pressure in the brain-computer interface space, potentially speeding up the timeline for advanced human-AI hybrid systems. The competition between major AI leaders could drive faster innovation in this critical area.
AGI Progress (+0.03%): Brain-computer interfaces represent a significant step toward human-AI integration and could provide new pathways for AI systems to understand and interface with human cognition. The involvement of OpenAI's funding suggests potential synergies with their AGI research efforts.
AGI Date (-1 days): Competition between Altman and Musk in brain-computer interfaces, combined with OpenAI's potential backing, likely accelerates research and development in human-AI integration technologies. This competitive dynamic could significantly speed up progress toward more advanced AI-human hybrid systems.